{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T04:42:46Z","timestamp":1767501766635,"version":"3.48.0"},"reference-count":133,"publisher":"The Royal Society","issue":"1222","license":[{"start":{"date-parts":[[1984,3,22]],"date-time":"1984-03-22T00:00:00Z","timestamp":448761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/royalsociety.org\/journals\/ethics-policies\/data-sharing-mining\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1984,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>EB virus is a herpesvirus that infects all human communities. The infection is life-long and usually asymptomatic. Excessive reaction to primary infection leads to infectious mononucleosis while immunological failures give fatal lymphoproliferative diseases. The virus is associated with endemic Burkitt\u2019s lymphoma and undifferentiated nasopharyngeal carcinoma. In world cancer terms Burkitt\u2019s lymphoma is insignificant, but nasopharyngeal carcinoma has a high incidence in certain important populations. By analogy with herpesvirus-induced animal cancers, prevention of infection should greatly reduce subsequent development of tumours. A prototype vaccine has therefore been produced based on the virusdetermined antigen (MA gp340) that elicits virus-neutralizing antibodies. A sensitive assay has permitted the elaboration of an efficient antigen preparation method and the product has been rendered highly immunogenic, as tested in mice and rabbits, by incorporation in liposomes. The only animal suitable for experimental EB virus infection is the little-known cottontop tamarin; a breeding colony has been successfully established and protection against virus challenge assessed in immunized tamarins. The overall structure of the antigen has been determined in preparation for future production by synthesis or rDNA technology.<\/jats:p>","DOI":"10.1098\/rspb.1984.0019","type":"journal-article","created":{"date-parts":[[2006,12,15]],"date-time":"2006-12-15T17:06:33Z","timestamp":1166202393000},"page":"1-20","source":"Crossref","is-referenced-by-count":15,"title":["The Leeuwenhoek Lecture, 1983 A prototype vaccine to prevent Epstein-Barr virus-associated tumours"],"prefix":"10.1098","volume":"221","member":"175","reference":[{"key":"p_1","doi-asserted-by":"crossref","unstructured":"Abo W. Takada K. Kamada M. Imamura M. Motoya T. Iwanga M. Aya T. Yano S. Nakao T. &Osato T. 1982 Evolution of infectious mononucleosis into Epstein-Barr virus carrying monoclonal malignant Iymphoma. Lancet i 1272-1276.","DOI":"10.1016\/S0140-6736(82)92842-2"},{"key":"p_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910200403"},{"key":"p_3","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910230605"},{"key":"p_4","first-page":"1253","article-title":"New clinical manifestations of Epstein-Barr virus infection","author":"Anon","year":"1982","journal-title":"Lancetii"},{"key":"p_5","doi-asserted-by":"crossref","unstructured":"Anon. 1983 Prevention of primary liver cancer. Lancet i 463-465.","DOI":"10.1016\/S0140-6736(83)91454-X"},{"key":"p_6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197402142900704"},{"key":"p_7","first-page":"601","article-title":"Histopathological definition of Burkitt's tumour","volume":"40","author":"Berard C.","year":"1969","journal-title":"Bull. W. H. O."},{"key":"p_8","first-page":"153","article-title":"The control of Marek's disease with special reference to the United Kingdom","volume":"43","author":"Biggs P. M.","year":"1974","journal-title":"Acta Vet. Brno"},{"key":"p_9","doi-asserted-by":"publisher","DOI":"10.1038\/298030a0"},{"key":"p_10","doi-asserted-by":"publisher","DOI":"10.1258\/002367781780958685"},{"key":"p_11","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.18004619704"},{"key":"p_12","doi-asserted-by":"crossref","unstructured":"Burkitt D. 1962a Determining the climatic limitations of a children's cancer common in Africa. Br. med. J. 2 1019-1023.","DOI":"10.1136\/bmj.2.5311.1019"},{"key":"p_13","doi-asserted-by":"publisher","DOI":"10.1038\/194232a0"},{"key":"p_14","unstructured":"Burkitt D. 1963 A Iymphoma syndrome in tropical Africa. In International review of experimental pathology (ed. G. W. Richter & M. A. Epstein) vol. 2 pp. 67-138. New York and London: Academic Press."},{"key":"p_15","first-page":"19","article-title":"Etiology of Burkitt's Iymphoma - an alternative hypothesis to a vectored virus. J.natn","volume":"42","author":"Burkitt D. P.","year":"1969","journal-title":"Cancer Inst."},{"key":"p_16","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197401)33:1<184::AID-CNCR2820330127>3.0.CO;2-T"},{"key":"p_17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197312202892501"},{"key":"p_18","doi-asserted-by":"publisher","DOI":"10.1038\/221744a0"},{"key":"p_19","doi-asserted-by":"crossref","unstructured":"Cleary M. L. Chao J. Warnke R. & Sklar J. 1983a Immunoglobulin gene rearrangement as a diagnostic criterion of B cell Iymphoma. Proc. natn. Acad. Sci. U.S.A. (In the press.)","DOI":"10.1073\/pnas.81.2.593"},{"key":"p_20","unstructured":"Cleary M. L. Warnke R. & Sklar J. 19836 Monoclonality of B Iymphocyte proliferations in cardiac transplant recipients:clonal analysis based on immunoglobulin gene rearrangements. N. Engl. J. Med. (Submitted.)"},{"key":"p_21","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910050302"},{"key":"p_22","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/65.4.687"},{"key":"p_23","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(79)80053-5"},{"key":"p_24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910240305"},{"key":"p_25","doi-asserted-by":"crossref","unstructured":"Crawford D. H. Sweny P. Edwards J. Janossy G. & Hoffbrand A. V. 1981 Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet i 10-13.","DOI":"10.1016\/S0140-6736(81)90115-X"},{"key":"p_26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.24.7824"},{"key":"p_27","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910130311"},{"key":"p_28","doi-asserted-by":"publisher","DOI":"10.1038\/274756a0"},{"key":"p_29","doi-asserted-by":"publisher","DOI":"10.1038\/305112a0"},{"key":"p_30","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/56.4.697"},{"key":"p_31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92673-3"},{"key":"p_32","doi-asserted-by":"crossref","unstructured":"Epstein M. A. & Achong B. G. (eds) 1979a The Epstein-Barr virus pp. 1-459. Berlin Heidelberg and New York: Springer.","DOI":"10.1007\/978-3-642-67236-1_1"},{"key":"p_33","doi-asserted-by":"crossref","unstructured":"Epstein M. A. & Achong B. G. 19796 Introduction and general biology of the virus. In The Epstein-Barr virus (ed. M. A. Epstein & B. G. Achong) pp. 1-22. Berlin Heidelberg and New York: Springer.","DOI":"10.1007\/978-3-642-67236-1_1"},{"key":"p_34","doi-asserted-by":"crossref","unstructured":"Epstein M. A. & Achong B. G. 1979 c The relationship of the virus to Burkitt's Iymphoma. In The Epstein-Barr virus (ed. M. A. Epstein &B. G. Achong) pp. 321-337. Berlin Heidelberg and New York: Springer.","DOI":"10.1007\/978-3-642-67236-1_14"},{"key":"p_35","doi-asserted-by":"crossref","unstructured":"Epstein M. A. & Barr Y. M. 1964 Cultivation in vitro of human Iymphoblasts from Burkitt's malignant Iymphoma. Lancet i 252-253.","DOI":"10.1016\/S0140-6736(64)92354-2"},{"key":"p_36","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/34.2.231"},{"key":"p_37","doi-asserted-by":"crossref","unstructured":"Epstein M. A. Achong B. G. & Barr Y. M. 1964a Virus particles in cultured Iymphoblasts from Burkitt's Iymphoma. Lancet i 702-703.","DOI":"10.1016\/S0140-6736(64)91524-7"},{"key":"p_38","first-page":"637","article-title":"6 Avian tumor virus behaviour as a guide in the investigation of a human neoplasm","volume":"17","author":"Epstein M. A.","year":"1964","journal-title":"Natn. Cancer Inst. Monographs"},{"key":"p_39","doi-asserted-by":"crossref","unstructured":"Epstein M. A. Hunt R. D. & Rabin H. 1973a Pilot experiments with EB virus in owl monkeys ( Aotustrivirgatus). I. Reticuloproliferative disease in an inoculated animal. Int. J .Cancer 12 309-318.","DOI":"10.1002\/ijc.2910120202"},{"key":"p_40","first-page":"257","article-title":"Clinical consequences of Epstein-Barr virus infection and possible control by an antiviral vaccine. Clin. exp","volume":"53","author":"Epstein M. A.","year":"1983","journal-title":"Immunol."},{"key":"p_41","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910120203"},{"key":"p_42","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910150103"},{"key":"p_43","first-page":"201","article-title":"Tissue culture of mouse leukemic cells","volume":"2","author":"Fischer G. A.","year":"1957","journal-title":"Proc. Am. Ass. Cancer Res."},{"key":"p_44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1958.tb54884.x"},{"key":"p_45","doi-asserted-by":"crossref","unstructured":"Gaston J. S. H. Rickinson A. B. & Epstein M. A. 1982 Epstein-Barr-virus-specific T-cell memory in renal-allograft recipients under long-term immunosuppression. Lancet i 923-925.","DOI":"10.1016\/S0140-6736(82)91930-4"},{"key":"p_46","first-page":"71","article-title":"Comparative studies of Epstein-Barr virus strains from Ghana and the United States","volume":"17","author":"Gerber P.","year":"1976","journal-title":"J. Cancer"},{"key":"p_47","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(71)90107-3"},{"key":"p_48","first-page":"781","article-title":"Infectious mononucleosis in children. Evaluation of Epstein-Barr-virus-specific serological data. J. Am. med","volume":"237","author":"Ginsburg C. M.","year":"1977","journal-title":"Ass."},{"key":"p_49","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/127.4.471"},{"key":"p_50","unstructured":"Gross L. 1961 Oncogenic viruses 1st edition pp. 1-393. Oxford London New York and Paris: Pergamon Press."},{"key":"p_51","first-page":"182","article-title":"Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years. Yale J. hiol","volume":"47","author":"Hallee T. J.","year":"1974","journal-title":"Med."},{"key":"p_52","first-page":"4253","article-title":"Clinical spectrum of Iymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus","volume":"41","author":"Hanto D. W.","year":"1981","journal-title":"Cancer Res."},{"key":"p_53","doi-asserted-by":"crossref","unstructured":"Henle G. & Henle W. 19796 The virus as the etiologic agent of infectious mononucleosis. In The Epstein-Barr virus (ed. M. A. Epstein &B. G. Achong) pp. 297-320. Berlin Heidelberg and New York: Springer.","DOI":"10.1007\/978-3-642-67236-1_13"},{"key":"p_54","doi-asserted-by":"crossref","unstructured":"Henle W. & Henle G. 1979a Seroepidemiology of the virus. In The Epstein-Barr virus (ed. M. A. Epstein & B. G. Achong) pp. 61-78. Berlin Heidelberg and New York: Springer Verlag.","DOI":"10.1007\/978-3-642-67236-1_4"},{"key":"p_55","first-page":"262","article-title":"The transmission of infectious mononucleosis. Am. J. med","volume":"229","author":"Hoagland R. J.","year":"1955","journal-title":"Sci."},{"key":"p_56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.5.2979"},{"key":"p_57","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(76)90369-7"},{"key":"p_58","first-page":"1309","article-title":"Studies of the Epstein-Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein-Barr virus and C3d","volume":"130","author":"Hutt-Fletcher L. M.","year":"1983","journal-title":"Immunol."},{"key":"p_59","first-page":"428","article-title":"Systemic lymphoblastic response to antithymocyte globulin in renal allograft recipients: an initial report. J.surg","volume":"24","author":"Iwatsuki S.","year":"1978","journal-title":"Res."},{"key":"p_60","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910310115"},{"key":"p_61","first-page":"1365","article-title":"Surface markers on human B and T Iymphocytes. II. Presence of Epstein-Barr virus receptors on B Iymphocytes. J. exp","volume":"138","author":"Jondal M.","year":"1973","journal-title":"Med."},{"key":"p_62","first-page":"1","article-title":"Alterations of the immunological specificity of plasma membranes of cells infected with Marek's disease and turkey herpesviruses. J. gen","volume":"25","author":"Kaaden O. R.","year":"1974","journal-title":"Virol."},{"key":"p_63","doi-asserted-by":"crossref","unstructured":"Kinlen L. J. Sheil A. G. R. Peto J. & Doll R. 1979 Collaborative LTnited Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br. med. J. 2 1461-1466.","DOI":"10.1136\/bmj.2.6203.1461"},{"key":"p_64","doi-asserted-by":"publisher","DOI":"10.1007\/BF02381684"},{"key":"p_65","doi-asserted-by":"publisher","DOI":"10.1258\/002367783781070867"},{"key":"p_66","doi-asserted-by":"crossref","unstructured":"Klein G. 1979 The relationship of the virus to nasopharyngeal carcinoma. In The Epstein-Barr virus (ed. M. A. Epstein & B. G. Achong) pp. 339-350. Berlin Heidelberg and New York: Springer.","DOI":"10.1007\/978-3-642-67236-1_15"},{"key":"p_67","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19801101)46:9<2100::AID-CNCR2820460932>3.0.CO;2-G"},{"key":"p_68","doi-asserted-by":"publisher","DOI":"10.1038\/253071a0"},{"key":"p_69","doi-asserted-by":"publisher","DOI":"10.1038\/298474a0"},{"key":"p_70","first-page":"293","article-title":"Chromosome evolution in the owl monkey","volume":"54","author":"Ma N. S. F.","year":"1981","journal-title":"Anthropol."},{"key":"p_71","first-page":"1022","article-title":"Chromosome polymorphism and banding patterns in the owl monkey (Aotus)","volume":"26","author":"Ma N. S. F.","year":"1976","journal-title":"Lab. Anim. Sci."},{"key":"p_72","doi-asserted-by":"publisher","DOI":"10.1159\/000459804"},{"key":"p_73","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(79)80939-4"},{"key":"p_74","first-page":"4284","article-title":"Cellular immune defects to Epstein-Barr virus-determined antigens in young males","volume":"41","author":"Masucci M. G.","year":"1981","journal-title":"Cancer Res."},{"key":"p_75","first-page":"378","article-title":"Herpesvirus saimiri. II. An experimentally induced primate disease resembling reticulum cell sarcoma","volume":"19","author":"Melendez L. V.","year":"1969","journal-title":"Lab. Anim. Care"},{"key":"p_76","doi-asserted-by":"crossref","unstructured":"Miller G. 1979 Experimental carcinogenicity by the virus vivo. In The Epstein-Barr virus (ed. M. A. Epstein & B. G. Achong) pp. 351-372. Berlin Heidelberg and New York: Springer.","DOI":"10.1007\/978-3-642-67236-1_16"},{"key":"p_77","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.69.2.383"},{"key":"p_78","doi-asserted-by":"crossref","unstructured":"Miller G. Shope T. Coope D. Waters L. Pagano J. Bornkamm G. W. & Henle W. 1977 Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumour incidence histologic spectrum antibody responses demonstration of viral DNA and characterization of viruses. J. exp.Med. 145 948-967.","DOI":"10.1084\/jem.145.4.948"},{"key":"p_79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.7.4247"},{"key":"p_80","doi-asserted-by":"publisher","DOI":"10.1038\/276715a0"},{"key":"p_81","doi-asserted-by":"crossref","unstructured":"Morgan A. J. Epstein M. A. & North J. R. 1983a Comparative immunogenicity studies on Epstein-Barr (EB) virus membrane antigen (MA) with novel adjuvants in mice rabbits and cotton-top tamarins. J. med. Virol. (In the press.)","DOI":"10.1002\/jmv.1890130310"},{"key":"p_82","first-page":"455","article-title":"6 Purification and properties of the gp 340 component of Epstein-Barr (EB) virus membrane antigen (MA) in an immunogenic form. J. gen","volume":"64","author":"Morgan A. J.","year":"1983","journal-title":"Virol."},{"key":"p_83","doi-asserted-by":"crossref","unstructured":"Morgan A. J. Smith A. R. Barker R. N. & Epstein M. A. 1983c A structural investigation of the Epstein-Barr (EB) virus membrane antigen glycoprotein gp 340. J. gen. Virol. (In the press.)","DOI":"10.1099\/0022-1317-65-2-397"},{"key":"p_84","first-page":"233","article-title":"Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro. J. gen","volume":"17","author":"Moss D. J.","year":"1972","journal-title":"Virol."},{"key":"p_85","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197802)41:2<578::AID-CNCR2820410226>3.0.CO;2-8"},{"key":"p_86","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1128\/IAI.36.3.1209-1216.1982","article-title":"In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes","volume":"36","author":"Naylor P. T.","year":"1982","journal-title":"Infect. Immun."},{"key":"p_87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197002122820704"},{"key":"p_88","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197606172942501"},{"key":"p_89","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910260216"},{"key":"p_90","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.23.7504"},{"key":"p_91","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(82)90097-0"},{"key":"p_92","doi-asserted-by":"publisher","DOI":"10.2307\/1588488"},{"key":"p_93","unstructured":"Pagano J. S. Huang C. H. Klein G. de The G. Shanmugaratnam K. & Yang C. S. 1975 Homology of Epstein-Barr virus DNA in nasopharyngeal carcinomas from Kenya Taiwan Singapore and Tunisia. In Oncogenesis and herpesviruses vol. 11(ed. G. de The M. A. Epstein & H. Zur Hausen) part 2 pp. 179-190. Lyon: IARC Scientific Publications No. 11."},{"key":"p_94","doi-asserted-by":"crossref","unstructured":"Pattengale P. K. Smith R. W. & Gerber P. 1973 Selective transformation of B Iymphocytes by EB virus. Lancet II 93.","DOI":"10.1016\/S0140-6736(73)93286-8"},{"key":"p_95","unstructured":"Payne L. N. Frazier J. A. & Powell P. C. 1976 Pathogenesis of Marek's disease. In International review of experimental pathology (ed. G. W. Richter & M. A. Epstein) vol. 16 pp. 59-154. New York San Francisco and London: Academic Press."},{"key":"p_96","first-page":"989","article-title":"Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens induced by the virus. J. natn","volume":"45","author":"Pearson G.","year":"1970","journal-title":"Cancer Inst."},{"key":"p_97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.6.2546"},{"key":"p_98","first-page":"492","article-title":"Malignancies associated with immunosuppressive or cytotoxic therapy","volume":"83","author":"Penn I.","year":"1978","journal-title":"Surgery"},{"key":"p_99","doi-asserted-by":"crossref","unstructured":"Pereira M. S. Blake J. M. &Macrae A. D. 1969 EB virus antibody at different ages. Br. med. J. 4 526-527.","DOI":"10.1136\/bmj.4.5682.526"},{"key":"p_100","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1982.107"},{"key":"p_101","doi-asserted-by":"crossref","unstructured":"Pope J. H. 1979 Transformation by the virus in vitro. In The Epstein-Barr virus (ed. M. A. Epstein & B. G. Achong) pp. 205-223. Berlin Heidelberg and New York: Springer.","DOI":"10.1007\/978-3-642-67236-1_10"},{"key":"p_102","doi-asserted-by":"crossref","unstructured":"Purtilo D. T. 1980 Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals. Lancet i 300-303.","DOI":"10.1016\/S0140-6736(80)90792-8"},{"key":"p_103","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197410032911415"},{"key":"p_104","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90923-8"},{"key":"p_105","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910230612"},{"key":"p_106","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(80)90103-8"},{"key":"p_107","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910110302"},{"key":"p_108","first-page":"4216","article-title":"Long-term T-cell-mediated immunity to Epstein-Barr virus","volume":"41","author":"Rickinson A. B.","year":"1981","journal-title":"Cancer Res."},{"key":"p_109","doi-asserted-by":"publisher","DOI":"10.1038\/283865a0"},{"key":"p_110","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.2.749"},{"key":"p_111","unstructured":"Shanmugaratnam K. 1971 Studies on the etiology of nasopharyngeal carcinoma. In International review of experimental pathology (ed. G. W. Richter & M. A. Epstein) vol. 10 pp. 361-413. New York and London: Academic Press."},{"key":"p_112","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.70.9.2487"},{"key":"p_113","doi-asserted-by":"publisher","DOI":"10.1038\/306480a0"},{"key":"p_114","doi-asserted-by":"crossref","unstructured":"Strauch B. Andrews L-L. Siegel N. & Miller G. 1974 Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. Lancet i 234-237.","DOI":"10.1016\/S0140-6736(74)92546-X"},{"key":"p_115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1128\/JVI.32.3.885-894.1979","article-title":"Correlation between Epstein-Barr virus membrane antigen and three large cell surface glycoproteins","volume":"32","author":"Strnad B. C.","year":"1979","journal-title":"J. Virol."},{"key":"p_116","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.4.1622"},{"key":"p_117","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840010502"},{"key":"p_118","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.24.7837"},{"key":"p_119","first-page":"573","article-title":"Production of EB virus by normal human nasopharyngeal epithelial cells exposed to the virus vitro","author":"Thompson J. L.","year":"1983","journal-title":"Ann. Virol. 134 E"},{"key":"p_120","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/JVI.32.2.458-467.1979","article-title":"The polypeptides of the Epstein-Barr virus membrane antigen complex","volume":"32","author":"Thorley-Lawson D. A.","year":"1979","journal-title":"J. Virol."},{"key":"p_121","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.9.5307"},{"key":"p_122","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/JVI.43.2.730-736.1982","article-title":"Identification and isolation of the main component (gp 350-gp 220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo","volume":"43","author":"Thorley-Lawson D. A.","year":"1982","journal-title":"J. Virol."},{"key":"p_123","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910170505"},{"key":"p_124","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910200503"},{"key":"p_125","doi-asserted-by":"crossref","unstructured":"University Health Physicians and P.H.L.S. Laboratories. 1971 Infectious mononucleosis and its relationship to EB virus antibody. Br. med. J. 4 643-646.","DOI":"10.1136\/bmj.4.5788.643"},{"key":"p_126","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91744-0"},{"key":"p_127","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198204000-00002"},{"key":"p_128","first-page":"449","article-title":"The Epstein-Barr virus receptor is distinct from the C3 receptor. J. gen","volume":"64","author":"Wells A.","year":"1983","journal-title":"Virol."},{"key":"p_129","doi-asserted-by":"crossref","unstructured":"Wolf H. Zur Hausen H. & Becker V. 1973 EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature new Biol. 244 245-247.","DOI":"10.1038\/newbio244245a0"},{"key":"p_130","unstructured":"Yao Q. Y. Rickinson A. B. & Epstein M. A. 1983a A reinvestigation of the Epstein-Barr virus carrier state in healthy seropositive individuals. (Submitted.)"},{"key":"p_131","unstructured":"Yao Q. Y. Rickinson A. B. Gaston J. S. H. & Epstein M. A. 19836 In vitro analysis of the Epstein-Barr virus-host balance in long-term renal allograft patients. (Submitted.)"},{"key":"p_132","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910200305"},{"key":"p_133","first-page":"539","article-title":"Can Epstein-Barr virus infect and transform all the B-lymphocytes of human cord blood? J. gen","volume":"64","author":"Zerbini M.","year":"1983","journal-title":"Virol."}],"container-title":["Proceedings of the Royal Society of London. Series B. Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rspb.1984.0019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/royalsocietypublishing.org\/rspb\/article-pdf\/221\/1222\/1\/173173\/rspb.1984.0019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/royalsocietypublishing.org\/rspb\/article-pdf\/221\/1222\/1\/173173\/rspb.1984.0019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T04:39:48Z","timestamp":1767501588000},"score":1,"resource":{"primary":{"URL":"https:\/\/royalsocietypublishing.org\/rspb\/article\/221\/1222\/1\/33639\/The-Leeuwenhoek-Lecture-1983-A-prototype-vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,3,22]]},"references-count":133,"journal-issue":{"issue":"1222","published-print":{"date-parts":[[1984,3,22]]}},"URL":"https:\/\/doi.org\/10.1098\/rspb.1984.0019","relation":{},"ISSN":["0080-4649","2053-9193"],"issn-type":[{"type":"print","value":"0080-4649"},{"type":"electronic","value":"2053-9193"}],"subject":[],"published":{"date-parts":[[1984,3,22]]}}}